DMTF1 antisense RNA 1 (DMTF1-AS1)

DMTF1 antisense RNA 1 (**DMTF1-AS1**) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the DMTF1 gene locus. Unlike protein-coding genes or classical receptor/enzyme targets, DMTF1-AS1 does not encode a protein. Instead, it is involved in the post-transcriptional regulation of the DMTF1 gene, which encodes a Myb-like transcription factor implicated in tumor suppression via the ARF-p53 pathway. Current research suggests that DMTF1-AS1 may play a regulatory role in cancer biology, particularly by influencing the expression or function of DMTF1 and, consequently, pathways involved in cell cycle control and apoptosis. However, there is no evidence that DMTF1-AS1 itself is a direct therapeutic target, nor are any drugs currently known to specifically target this lncRNA[3][4][5][6]. The majority of research and references in your search results relate to **DMTF1** (cyclin D binding myb-like transcription factor 1), which is a well-characterized transcription factor and known tumor suppressor. Your query, however, is about **DMTF1-AS1**, which is the corresponding antisense lncRNA. DMTF1 and DMTF1-AS1 are distinct molecular entities: DMTF1 is protein-coding; DMTF1-AS1 is not. DMTF1 antisense RNA 1 is not a receptor, enzyme, transporter, or other traditional drug target protein. DMTF1-AS1 sometimes appears in studies investigating cancer or gene expression, but it is not currently used as a biomarker or targeted by drugs. If you are seeking information specifically on therapeutic targets, DMTF1 (the transcription factor) and not DMTF1-AS1 would be relevant. DMTF1 has clear tumor suppressive functions and a mechanistic link to cancer development[2][3][4][5].

Other names

DMTF1-AS1DMTF1 antisense RNA 1